SEC Form 4 · accession 0001127602-15-030312
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Giltner
Director
Period of report
Nov 3, 2015
Accepted (ET)
Nov 4, 2015 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2015 | M | 7,500 | $31.035 | A | 7,500 | D | |
| Common StockF1 | Nov 3, 2015 | S | 7,500 | $153.2229 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $31.035 | Nov 3, 2015 | M | 7,500 | D | Apr 29, 2010 | Apr 29, 2019 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $153.42 to $153.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.